Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine and nifedipine in rats

被引:18
作者
Konno, Y
Sekimoto, M
Nemoto, K
Degawa, M
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Dept Mol Toxicol, Shizuoka 4228526, Japan
[2] Univ Shizuoka, Sch Pharmaceut Sci, COE Program 21st Century, Shizuoka 4228526, Japan
基金
日本学术振兴会;
关键词
nicardipine; nifedipine; cytochrome p450; CYP2B; CYP3A; induction; rat liver;
D O I
10.1016/j.taap.2003.12.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Male and female of F344 rats were treated per os with nicardipine (Nic) and nifedipine (Nif), and changes in the levels of mRNA and protein of hepatic cytochrome P450 (P450) enzymes, CYP2B1, CYP2B2, CYP3A1, CYP3A2, CYP3A9, and CYP3A18 were examined. Furthermore, hepatic microsomal activities for pentoxyresorufin O-dealkylation (PROD) and nifedipine oxidation, which are mainly mediated by CYP2B and CYP3A subfamily enzymes, respectively, were measured. Analyses of RT-PCR and Western blotting revealed that Nic and Nif induced predominantly CYP3A and CYP2B enzymes, respectively. As for the gene activation of CYP2B enzymes, especially CYP2B 1, Nif showed high capacity in both sexes of rats, whereas Nic did a definite capacity in the males but little in the females. Gene activations of CYP3A1, CYP3A2, and CYP3A18 by Nic occurred in both sexes of rats, although that of CYP3A9 did only in the male rats. Although gene activations of CYP3A1 and CYP3A2 by Nif were observed in both sexes of rats, a slight activation of the CYP3A9 gene occurred only in female rats, and the CYP3A18 gene activation, in neither male nor female rats. Thus, changes in levels of the mRNA or protein of CYP2B and CYP3A enzymes, especially CYP2B1 and CYP3A2, were closely correlated with those in hepatic PROD and nifedipine oxidation activities, respectively. The present findings demonstrate for the first time the sex difference in the Nic- and Nif-mediated induction of hepatic P450 enzymes in rats and further indicate that Nic and Nif show different specificities and sex dependencies in the induction of hepatic P450 enzymes. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:20 / 28
页数:9
相关论文
共 31 条
[1]  
Agrawal AK, 1996, MOL PHARMACOL, V49, P523
[2]   Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions [J].
Bertz, RJ ;
Granneman, GR .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :210-258
[3]  
Bourrie M, 1996, J PHARMACOL EXP THER, V277, P321
[4]   CYTOCHROME-P450 SPECIFICITIES OF ALKOXYRESORUFIN O-DEALKYLATION IN HUMAN AND RAT-LIVER [J].
BURKE, MD ;
THOMPSON, S ;
WEAVER, RJ ;
WOLF, CR ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) :923-936
[5]   Clinically significant drug interactions with cyclosporin - An update [J].
Campana, C ;
Regazzi, MB ;
Buggia, I ;
Molinaro, M .
CLINICAL PHARMACOKINETICS, 1996, 30 (02) :141-179
[6]   REGULATION OF 2 MEMBERS OF THE STEROID-INDUCIBLE CYTOCHROME P450 SUBFAMILY (3A) IN RATS [J].
COOPER, KO ;
REIK, LM ;
JAYYOSI, Z ;
BANDIERA, S ;
KELLEY, M ;
RYAN, DE ;
DANIEL, R ;
MCCLUSKEY, SA ;
LEVIN, W ;
THOMAS, PE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 301 (02) :345-354
[7]   HEPATOCARCINOGENIC HETEROCYCLIC AROMATIC-AMINES THAT INDUCE CYTOCHROME-P-448 ISOZYMES, MAINLY CYTOCHROME-P-448H (P-450IA2), RESPONSIBLE FOR MUTAGENIC ACTIVATION OF THE CARCINOGENS IN RAT-LIVER [J].
DEGAWA, M ;
TANIMURA, S ;
AGATSUMA, T ;
HASHIMOTO, Y .
CARCINOGENESIS, 1989, 10 (06) :1119-1122
[8]  
Drocourt L, 2001, DRUG METAB DISPOS, V29, P1325
[9]   PREGNENOLONE 16-ALPHA-CARBONITRILE-INDUCIBLE P-450 GENE FAMILY - GENE CONVERSION AND DIFFERENTIAL REGULATION [J].
GONZALEZ, FJ ;
SONG, BJ ;
HARDWICK, JP .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (08) :2969-2976
[10]   Change in the gene expression of hepatic tamoxifen-metabolizing enzymes during the process of tamoxifen-induced hepatocarcinogenesis in female rats [J].
Kasahara, T ;
Hashiba, M ;
Harada, T ;
Degawa, M .
CARCINOGENESIS, 2002, 23 (03) :491-498